BIB vs. IBBQ
BIB (ProShares Ultra Nasdaq Biotechnology) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while IBBQ is a Health & Biotech Equities fund tracking the NASDAQ / Biotechnology. Both are passively managed. Over the past 5 years, BIB returned -0.74%/yr vs 4.77%/yr for IBBQ. With a 0.99 correlation, they move nearly in lockstep. BIB charges 0.95%/yr vs 0.00%/yr for IBBQ.
Performance
BIB vs. IBBQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 12.50% return, which is significantly higher than IBBQ's 8.67% return.
BIB
- 1D
- 1.97%
- 1M
- 9.49%
- YTD
- 12.50%
- 6M
- 8.62%
- 1Y
- 100.86%
- 3Y*
- 19.65%
- 5Y*
- -0.74%
- 10Y*
- 9.71%
IBBQ
- 1D
- 0.93%
- 1M
- 5.09%
- YTD
- 8.67%
- 6M
- 7.00%
- 1Y
- 48.86%
- 3Y*
- 15.18%
- 5Y*
- 4.77%
- 10Y*
- —
BIB vs. IBBQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 12.50% | 59.21% | -9.84% | -1.06% | -28.85% | -16.88% |
IBBQ Invesco Nasdaq Biotechnology ETF | 8.67% | 33.32% | -0.63% | 4.73% | -10.41% | -6.24% |
Correlation
The correlation between BIB and IBBQ is 0.99 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.99 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.99 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.99 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021 | 0.99 |
The correlation between BIB and IBBQ has been stable across timeframes, ranging from 0.99 to 0.99 - a consistent structural relationship.
BIB vs. IBBQ - Sectors Allocation Comparison
Sectors
BIB
IBBQ
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BIB
IBBQ
Financial Services
BIB
IBBQ
Basic Materials
BIB
-
IBBQ
-
Communication Services
BIB
-
IBBQ
-
Consumer Cyclical
BIB
-
IBBQ
-
Consumer Defensive
BIB
-
IBBQ
-
Energy
BIB
-
IBBQ
-
Industrials
BIB
-
IBBQ
-
Real Estate
BIB
-
IBBQ
-
Technology
BIB
-
IBBQ
-
Utilities
BIB
-
IBBQ
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. IBBQ — Risk / Return Rank
BIB
IBBQ
BIB vs. IBBQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and Invesco Nasdaq Biotechnology ETF (IBBQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIB | IBBQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | -0.28 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.40 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 5.99 | 5.89 | +0.11 |
| Martin ratioReturn relative to average drawdown | 18.30 | 18.75 | -0.45 |
Loading charts...
Drawdowns
BIB vs. IBBQ - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, which is greater than IBBQ's maximum drawdown of -37.94%. Use the drawdown chart below to compare losses from any high point for BIB and IBBQ.
Loading charts...
Drawdown Indicators
| BIB | IBBQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -37.94% | -29.30% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -8.34% | -8.58% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -23.66% | -21.64% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -37.94% | -27.92% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | — | — |
Current DrawdownCurrent decline from peak | -17.29% | 0.00% | -17.29% |
Average DrawdownAverage peak-to-trough decline | -32.71% | -16.66% | -16.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.53% | 2.61% | +2.92% |
Volatility
BIB vs. IBBQ - Volatility Comparison
ProShares Ultra Nasdaq Biotechnology (BIB) has a higher volatility of 13.56% compared to Invesco Nasdaq Biotechnology ETF (IBBQ) at 6.82%. This indicates that BIB's price experiences larger fluctuations and is considered to be riskier than IBBQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | IBBQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.56% | 6.82% | +6.74% |
Volatility (6M)Calculated over the trailing 6-month period | 31.65% | 15.72% | +15.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.43% | 20.03% | +20.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.60% | 21.92% | +21.68% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.39% | 21.87% | +24.52% |
BIB vs. IBBQ - Expense Ratio Comparison
BIB has a 0.95% expense ratio, which is higher than IBBQ's 0.00% expense ratio.
Dividends
BIB vs. IBBQ - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.55%, less than IBBQ's 0.83% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.55% | 0.77% | 1.69% | 0.07% | 0.03% | 0.00% |
IBBQ Invesco Nasdaq Biotechnology ETF | 0.83% | 0.90% | 1.14% | 0.81% | 0.76% | 0.63% |
Frequently Asked Questions
With a correlation of 0.99, BIB and IBBQ move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
BIB has higher volatility (13.56%) compared to IBBQ (6.82%). In terms of maximum drawdown, BIB dropped -67.24% vs IBBQ's -37.94%.
On 5-year performance, IBBQ leads with 4.77% vs -0.74% for BIB. On fees, IBBQ is cheaper at 0.00% per year. On volatility, IBBQ has been the lower-risk option at 6.82%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IBBQ has performed better with a 4.77% return vs -0.74%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBBQ is cheaper with a 0.00% expense ratio, compared with 0.95% for BIB.
IBBQ has the higher dividend yield at 0.83%, compared with 0.55% for BIB.
BIB is categorized as Leveraged Equities, while IBBQ is Health & Biotech Equities. BIB tracks NASDAQ Biotechnology Index (200%), while IBBQ tracks NASDAQ / Biotechnology. They also come from different issuers: ProShares and Invesco. Their fees differ too: 0.95% for BIB and 0.00% for IBBQ.
BIB currently has the higher Sharpe Ratio (2.51 vs 2.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and IBBQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer